Franklin Resources’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.68M Buy
115,488
+6,051
+6% +$58.4K ﹤0.01% 2072
2026
Q1
$812K Buy
109,437
+23,748
+28% +$250K ﹤0.01% 2264
2025
Q4
$1.01M Sell
85,689
-1,076,459
-93% -$11.6M ﹤0.01% 2076
2025
Q3
$8.97M Sell
1,162,148
-316,132
-21% -$2.21M ﹤0.01% 1203
2025
Q2
$10.8M Buy
1,478,280
+12,381
+0.8% +$99.9K ﹤0.01% 1109
2025
Q1
$13.9M Buy
1,465,899
+4,493
+0.3% +$56.1K ﹤0.01% 1003
2024
Q4
$24.1M Sell
1,461,406
-582,434
-28% -$9.05M 0.01% 845
2024
Q3
$28.2M Buy
2,043,840
+39,740
+2% +$622K 0.01% 782
2024
Q2
$27.8M Sell
2,004,100
-122,498
-6% -$1.74M 0.01% 750
2024
Q1
$33.4M Buy
2,126,598
+655,556
+45% +$10.1M 0.01% 711
2023
Q4
$23.8M Sell
1,471,042
-2,854
-0.2% -$46.7K 0.01% 708
2023
Q3
$18.1M Buy
1,473,896
+1,000
+0.1% +$14.9K 0.01% 771
2023
Q2
$23.7M Buy
1,472,896
+77,310
+6% +$1.27M 0.01% 721
2023
Q1
$24.3M Buy
1,395,586
+142
+0% +$2.02K 0.01% 724
2022
Q4
$12.9M Sell
1,395,444
-6,157
-0.4% -$57.4K 0.01% 890
2022
Q3
$12.1M Buy
1,401,601
+17,844
+1% +$177K 0.01% 885
2022
Q2
$11.3M Buy
1,383,757
+1,738
+0.1% +$16.6K 0.01% 925
2022
Q1
$16.8M Buy
1,382,019
+237,512
+21% +$5M 0.01% 894
2021
Q4
$39M Sell
1,144,507
-9,982
-0.9% -$391K 0.01% 719
2021
Q3
$55.7M Buy
1,154,489
+3,533
+0.3% +$164K 0.02% 616
2021
Q2
$52M Sell
1,150,956
-2,474
-0.2% -$110K 0.02% 641
2021
Q1
$55.6M Buy
1,153,430
+1,457
+0.1% +$75.9K 0.02% 588
2020
Q4
$62M Buy
1,151,973
+600
+0.1% +$27.1K 0.03% 530
2020
Q3
$42.5M Sell
1,151,373
-45,726
-4% -$1.7M 0.02% 592
2020
Q2
$44M Sell
1,197,099
-10,367
-0.9% -$287K 0.02% 560
2020
Q1
$33.3M Sell
1,207,466
-60,812
-5% -$1.82M 0.02% 559
2019
Q4
$37.1M Sell
1,268,278
-234,588
-16% -$5.59M 0.02% 612
2019
Q3
$28.7M Buy
1,502,866
+4,664
+0.3% +$109K 0.02% 663
2019
Q2
$32.9M Buy
1,498,202
+5,437
+0.4% +$119K 0.02% 643
2019
Q1
$30.5M Sell
1,492,765
-1,041
-0.1% -$18.1K 0.02% 635
2018
Q4
$18.8M Sell
1,493,806
-2,107
-0.1% -$31.4K 0.01% 716
2018
Q3
$23M Buy
1,495,913
+675,525
+82% +$9.34M 0.01% 744
2018
Q2
$10.8M Sell
820,388
-737,005
-47% -$8.11M 0.01% 908
2018
Q1
$12.7M Buy
1,557,393
+784,493
+101% +$6.36M 0.01% 885
2017
Q4
$6.85M Buy
+772,900
New +$7.13M ﹤0.01% 1021

Other funds holding NEO

Franklin Resources's NEO Position: Q2 2026 in Review

Franklin Resources increased its NeoGenomics (NEO) stake by 5.5% in Q2 2026, buying an estimated $58.4K and bringing the position to 115,488 shares worth $1.68M. The position accounts for ﹤0.01% of the portfolio, ranked #2072.

Franklin Resources first reported a position in NEO in Q4 2017 and has held it in 35 quarters since. The position peaked at $62M in Q4 2020. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.

  • Franklin Resources held 115,488 shares of NeoGenomics worth $1.68M as of Q2 2026.
  • Franklin Resources bought 6,051 NeoGenomics shares in Q2 2026, an estimated $58.4K.
  • NeoGenomics made up ﹤0.01% of Franklin Resources's portfolio in Q2 2026, its #2072 holding.
  • Franklin Resources first reported a position in NeoGenomics in Q4 2017 and has held it in 35 quarters since.
  • Franklin Resources's NeoGenomics position peaked at $62M in Q4 2020.
  • 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.